Inception Return
(11/1/2002)
|
7.57 %
|
|
YTD Return
|
-25.45 %
|
|
NAVPS
(11/25/2022)
|
$38.15
|
|
Change
|
$0.11 / 0.30 %
|
|
|
Growth of $10,000
(As of October 31, 2022)
|
|
MER
|
1.92 %
|
|
Assets ($mil)
|
$2,674.12
|
|
Rank (1Yr)
|
2007/2195
|
|
Std Dev (3Yr)
|
15.16 %
|
|
Volatility Ranking (3Yr)
|
7/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Front Fee Only
|
|
Max Front End
|
2.50 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The objective of the Fund is to provide long-term growth of capital through investments primarily in common stocks, including growth-oriented stocks, on a global basis. Future income is a secondary objective.
|
Fund Manager
Capital Group
Portfolio Manager
Carl M. Kawaja, Capital Group
Leo Hee, Capital Group
Jeremy Burge, Capital Group
Dawid Justus, Capital Group
Sub-Advisor
Capital Research and Management Company
|
|
Asset Allocation
(As of September 30, 2022)
|
Sector Allocation
(As of September 30, 2022)
|
Geographic Allocation
(As of September 30, 2022)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 3.29% |
| Microsoft Corp | US Equity | Technology | United States | 2.58% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 2.58% |
| Canada Government 0.00% 10-Nov-2022 | Cash and Equivalents | Cash and Cash Equivalent | Canada | 2.34% |
| Canada Government 0.00% 13-Oct-2022 | Cash and Equivalents | Cash and Cash Equivalent | Canada | 2.27% |
| Canada Government 0.00% 27-Oct-2022 | Cash and Equivalents | Cash and Cash Equivalent | Canada | 2.14% |
| Canada Government 0.00% 22-Dec-2022 | Cash and Equivalents | Cash and Cash Equivalent | Canada | 2.13% |
| Taiwan Semiconductor Manufactrg Co Ltd | International Equity | Technology | Asia/Pacific Rim | 2.12% |
| Canada Government 0.00% 08-Dec-2022 | Cash and Equivalents | Cash and Cash Equivalent | Canada | 1.69% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 1.52% |
Performance Data
(As of October 31, 2022)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
4.09
|
-1.91
|
-4.43
|
-25.45
|
-25.41
|
4.22
|
4.53
|
10.74
|
|
Benchmark
|
5.44
|
-1.66
|
-3.41
|
-15.21
|
-12.18
|
5.97
|
6.31
|
11.58
|
|
Quartile Ranking
|
3
|
2
|
3
|
4
|
4
|
3
|
3
|
1
|
|
Calendar Return (%)
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
|
Fund
|
10.01
|
28.42
|
22.86
|
-3.57
|
18.28
|
4.28
|
18.02
|
10.45
|
32.69
|
16.36
|
|
Benchmark
|
17.62
|
13.15
|
21.41
|
-1.79
|
16.29
|
5.18
|
16.88
|
13.97
|
32.40
|
13.73
|
|
Quartile Ranking
|
4
|
1
|
1
|
2
|
1
|
2
|
2
|
3
|
2
|
1
|